On 2025-05-14, Inozyme Pharma, Inc. (INZY) announced earnings per share of $-0.44 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.43.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.36 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.43 | $-0.44 |
| 2025-03-10 | 2024-12-31 | $-0.41 | $-0.42 |
| 2024-11-05 | 2024-09-30 | $-0.44 | $-0.39 |
| 2024-08-06 | 2024-06-30 | $-0.37 | $-0.44 |
| 2024-05-07 | 2024-03-31 | $-0.35 | $-0.38 |
| 2024-03-12 | 2023-12-31 | $-0.31 | $-0.35 |
| 2023-11-07 | 2023-09-30 | $-0.32 | $-0.29 |
| 2023-08-08 | 2023-06-30 | $-0.43 | $-0.35 |
| 2023-05-09 | 2023-03-31 | $-0.44 | $-0.40 |
| 2023-03-22 | 2022-12-31 | $-0.46 | $-0.42 |
| 2022-11-10 | 2022-09-30 | $-0.43 | $-0.38 |
| 2022-08-15 | 2022-06-30 | $-0.48 | $-0.38 |
| 2022-05-10 | 2022-03-31 | $-0.81 | $-0.71 |
| 2022-03-15 | 2021-12-31 | $-0.73 | $-0.79 |
| 2021-11-09 | 2021-09-30 | $-0.61 | $-0.60 |
| 2021-08-11 | 2021-06-30 | $-0.57 | $-0.53 |
| 2021-05-12 | 2021-03-31 | $-0.54 | $-0.47 |
| 2020-11-12 | 2020-09-30 | $-0.51 | $-1.55 |
| 2020-09-03 | 2020-06-30 | $-1.41 | $-7.57 |